| Product Code: ETC7633709 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Malignant Pleural Mesothelioma Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Malignant Pleural Mesothelioma Market - Industry Life Cycle |
3.4 Ireland Malignant Pleural Mesothelioma Market - Porter's Five Forces |
3.5 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Ireland Malignant Pleural Mesothelioma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the dangers of asbestos exposure leading to early diagnosis and treatment of malignant pleural mesothelioma. |
4.2.2 Advancements in medical technology and treatment options improving patient outcomes and survival rates. |
4.2.3 Growing research and development initiatives focused on finding more effective treatments for malignant pleural mesothelioma. |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities and expertise for the treatment of malignant pleural mesothelioma. |
4.3.2 High treatment costs associated with advanced therapies and medications for malignant pleural mesothelioma. |
4.3.3 Regulatory challenges and stringent approval processes for new treatments in the malignant pleural mesothelioma market. |
5 Ireland Malignant Pleural Mesothelioma Market Trends |
6 Ireland Malignant Pleural Mesothelioma Market, By Types |
6.1 Ireland Malignant Pleural Mesothelioma Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, By Opdivo (Nivolumab), 2021- 2031F |
6.1.4 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, By Yervoy (Ipilimumab), 2021- 2031F |
6.1.5 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, By MTG201, 2021- 2031F |
6.1.6 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, By CBP501, 2021- 2031F |
6.1.7 Ireland Malignant Pleural Mesothelioma Market Revenues & Volume, By Lurbinectedin, 2021- 2031F |
7 Ireland Malignant Pleural Mesothelioma Market Import-Export Trade Statistics |
7.1 Ireland Malignant Pleural Mesothelioma Market Export to Major Countries |
7.2 Ireland Malignant Pleural Mesothelioma Market Imports from Major Countries |
8 Ireland Malignant Pleural Mesothelioma Market Key Performance Indicators |
8.1 Average age at diagnosis of malignant pleural mesothelioma patients. |
8.2 Survival rates of patients diagnosed with malignant pleural mesothelioma. |
8.3 Number of clinical trials and research studies focused on malignant pleural mesothelioma treatments. |
8.4 Patient satisfaction scores with the quality of care received for malignant pleural mesothelioma. |
9 Ireland Malignant Pleural Mesothelioma Market - Opportunity Assessment |
9.1 Ireland Malignant Pleural Mesothelioma Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Ireland Malignant Pleural Mesothelioma Market - Competitive Landscape |
10.1 Ireland Malignant Pleural Mesothelioma Market Revenue Share, By Companies, 2024 |
10.2 Ireland Malignant Pleural Mesothelioma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here